Clinical trial
Comparison of Respiratory and Hemodynamic Effects of Dexmedetomidine vs. Propofol in High-Risk Patients Undergoing ERCP: A Prospective Randomized Controlled Study
NCT07166614 is registered in ClinicalTrials.gov with Sisli Hamidiye Etfal Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Respiratory and Hemodynamic Effects of Dexmedetomidine vs. Propofol in High-Risk Patients Undergoing ERCP: A Prospective Randomized Controlled Study
- Lead sponsor
- Sisli Hamidiye Etfal Training and Research Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 3, 2025
- Completion date
- April 15, 2026
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bradycardia, hypotension drug-induced, hypoxemia, respiratory depression